Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanapac GMP deficiencies

This article was originally published in The Tan Sheet

Executive Summary

Outlined by FDA in an April 19 letter to Dallas, Penn.-based Sanapac Co., problems include failure to package iron supplements in solid oral dosage form in unit-dose packaging. The company, which distributes products primarily on the East Coast, is recalling its products and adding child-proof caps to containers. Sanapac's iron-containing products include Sanapac Rooster brand pills, Rooster Kings, Super Kings Inner Man, Sanapac Inner Man Gold and Super Queens Inner Woman. FDA inspected the company's repackaging and distribution facility on Feb. 11. The agency also notes the company's dietary supplements are misbranded because their labeling bears National Drug Code listing numbers
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS089791

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel